NAFDAC Recalls Deekins Amoxycillin 500mg Capsules Following Severe Adverse Reactions
By DAYO ADESULU
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a recall for a specific batch of Deekins Amoxycillin 500mg Capsules due to reports of severe adverse drug reactions.
Details of the Recalled Batch
The affected batch, identified by lot number 4C639001, was manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd.
According to a statement released by NAFDAC on Wednesday via X (formerly Twitter), the recall was initiated following reports from a hospital that recorded three severe reactions in patients administered the capsules.
About Deekins Amoxycillin
Amoxicillin, a penicillin-based antibiotic, is commonly prescribed for bacterial infections such as:
- Tonsillitis
- Bronchitis
- Sinusitis
- Pneumonia
- Bacterial infections of the ear, nose, throat, skin, or urinary tract
NAFDAC’s Advice to Healthcare Professionals and the Public
NAFDAC has urged both healthcare professionals and consumers to:
- Immediately cease use of the affected batch.
- Report any adverse effects or suspicions of substandard medicines to the agency.
For concerns or reports, the agency can be contacted via:
- Toll-Free Number: 0800-162-3322
- Email: sf.alert@nafdac.gov.ng
Safety Measures
This recall underscores the importance of vigilance in monitoring the safety of pharmaceuticals to protect public health. Consumers and healthcare providers are encouraged to stay alert and cooperate with NAFDAC to ensure the affected batch is swiftly removed from circulation.
